About
Founded in 1977, New Enterprise Associates (NEA) is one of the world's largest and most active venture capital firms, with more than $28 billion in assets under management as of June 2025. Headquartered in Menlo Park, California with additional offices across the United States (including Maryland, New York, Pennsylvania, Colorado, Washington DC, and Florida), London, and the San Francisco Bay Area, NEA operates as a global venture capital platform focused on technology and healthcare sectors. The firm invests across all stages of company development, from seed through growth and public offerings, writing checks ranging from $1 million to $25 million depending on stage and opportunity. Since inception, NEA has deployed capital into nearly 1,000 companies, realizing over 650 liquidity events including more than 250 portfolio company IPOs and over 300 acquisitions. The current portfolio comprises approximately 1,186 companies, including 49 unicorns, with notable investments spanning seed-stage companies (average round size $4.36 million), Series A (average $23.3 million), and Series B rounds (average $39 million). NEA's investment approach emphasizes direct founder relationships and operator-led engagement, positioning the firm as a preferred co-investor alongside institutions like Sequoia Capital and Y Combinator. Recent notable exits include Verona Pharma (July 2025). The firm has maintained multiple active fund vehicles, including NEA 14, 15, 16, and 17, each with distinct vintage years and geographic mandates. NEA's mission centers on helping founders build transformational businesses that improve how people live, work, and play, offering strategic support and capital to entrepreneurs navigating scaling challenges and market validation.